TLC to Present High-Scoring Scientific Abstracts on Acute Pain through Moderated Sessions at ASRA Spring 2019
(WorldNews Business)

TLC to Present High-Scoring Scientific Abstracts on Acute Pain through Moderated Sessions at ASRA Spring 2019 SOUTH SAN FRANCISCO, CA andTAIPEI, Taiwan - March 25, 2019 - TLC(Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet medical need in osteoarthritis, pain management, ophthalmology and oncology, today announced the upcoming presentation of two scientific abstracts on TLC590 which have been accepted for the 44th Annual Regional Anesthesiology & Acute Pain Medicine Meetinghosted by the American Society of Regional Anesthesia and Pain Medicine (ASRA)....